Colorectal cancer that is caught in the early stages has a 5-year survival rate of over 90%.1 Yet, only 39% of cases2 are diagnosed in early stages due to low screening rates. When disease spreads to distant organs, the 5-year survival rate drops to 11%.3
Fortunately, Quest Diagnostics can help you and your patients screen for signs of colorectal cancer.
InSure® ONE™ is a convenient, at-home fecal immunochemical test (FIT) kit that only requires water-based sampling of one bowel movement. Colorectal cancer screening has never been easier. Reach more patients with InSure ONE.